Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flow from operating activities:
Net income	$ 73,757	$ 26,266
Adjustments to reconcile net income to cash flow from operating activities:
Depreciation and amortization	38,795	39,034
Share-based compensation	5,704	6,617
Excess tax benefits from share-based compensation	(1,591)	(1,390)
Impairment of assets	6,701	2,962
Equity in earnings of an investee	(592)	(859)
Cash flow from changes in certain assets and liabilities:
Trade receivables	(44,841)	(28,284)
Inventories	(54,882)	(36,452)
Prepaid expenses	84	3,055
Other current assets	(32,583)	(34,952)
Accounts payable	10,406	(13,392)
Deferred revenue	1,908	8,611
Certain other assets and liabilities	(36,836)	(71,190)
Net cash used in operating activities	(33,970)	(99,974)
Cash flow from investing activities:
Proceeds from sale of discontinued operations	0	2,520
Proceeds from maturities of investments	156,491	139,020
Proceeds from sale of investments	16,157	26,761
Payments for purchases of investments	(176,404)	(135,798)
Proceeds from sale of assets	283	182
Capital expenditures	(20,669)	(23,687)
Collections on purchased finance receivables	7,072	12,976
Increase in certain other assets	(4,549)	(9,183)
Net cash (used in) provided by investing activities	(21,619)	12,791
Cash flow from financing activities:
Dividends paid	(36,313)	(37,090)
Debt issuance costs	0	(1,733)
Debt borrowings	430,260	350,679
Debt repayments	(366,773)	(227,563)
Distributions of affiliates earnings to noncontrolling interest holders	(1,112)	(1,045)
Excess tax benefit from share-based compensation	1,591	1,390
Issuance of common shares	16,003	4,017
Repurchase of common shares	(2,896)	(57,591)
Net cash provided by financing activities	40,760	31,064
Effect of exchange rate changes on cash and cash equivalents	1,450	6,201
Decrease in cash and cash equivalents	(13,379)	(49,918)
Cash and cash equivalents at the beginning of the period	333,920	328,658
Cash and cash equivalents at the end of the period	$ 320,541	$ 278,740